- Home
- GALT vs MSLE Comparison
GALT vs MSLE Comparison
Compare GALT & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.04
Company Overview
Basic Information| Metric | GALT | MSLE |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.7M | 173.9M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | GALT | MSLE |
|---|---|---|
| Price | $3.04 | $13.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 231.8K | 58.2K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.15 | $10.64 |
| 52 Week High | $7.13 | $12.46 |
Technical Indicators
Market Signals| Indicator | GALT | MSLE |
|---|---|---|
| Relative Strength Index (RSI) | 48.30 | 77.07 |
| Support Level | $2.90 | $10.85 |
| Resistance Level | $3.24 | N/A |
| Average True Range (ATR) | 0.19 | 0.64 |
| MACD | 0.07 | 0.16 |
| Stochastic Oscillator | 62.86 | 93.91 |
Price Performance
Historical Comparison GALT
MSLE
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.